Track the 레이 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 레이 has logged 147 reports. Market capitalisation: €83.8bn. The latest transaction was filed on 21 September 2026 (Sale). Among the most active insiders: 미래에셋자산운용. Every trade is accessible without an account.
138
Insider Decl.
n/a
Thresholds
€3m
40 ops.
Buy Volume
€117,409
73 ops.
Sell Volume
Buys €3m€117,409 Sells
Fundamental score
Ranked 13,836 of 29,254 companies
53.4
score / 100
Value
67
Quality
40
FCF yld11%
Earn yld3.7%
EV/EBITDA9.6x
ROE1.3%
Gross mgn47%
Net mgn2.8%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
레이 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.